Company |
Amount Raised |
Biomet Inc. (August) |
$1B |
Salix Pharmaceuticals (March) |
$690M |
Elan Corp. plc (March) |
$381M |
Theravance Inc. (April) |
$212.9M |
Isis Pharmaceuticals Inc. (August) |
$201.25M |
Amarin Corp. plc (January) |
$150M |
Nektar Therapeutics Inc. (July) |
$125M |
Sequenom Inc. (September) |
$110M |
Vernalis plc (February) |
$103.8M |
ThromboGenics NV (March) |
$103.2M |